Compare Ganirelix (evidence A) and Oxytocin (evidence A) on mechanism, clinical status, safety, and dosing.
Ganirelix is a synthetic GnRH antagonist decapeptide (MW ~1570.4 g/mol) FDA-approved for the prevention of premature LH surges during controlled ovarian…
Oxytocin is an endogenous cyclic nonapeptide hormone (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 with a disulfide bridge between Cys1 and Cys6, MW ~1007.2 g/mol)…